Antibiotics Market Size, Share & Trends Report

Antibiotics Market Size, Share & Trends Analysis Report By Action Mechanism (Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors), By Drug Class (Penicillin, Cephalosporin), By Type (Branded, Generic), And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-149-8
  • Number of Pages: 145
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Table of Contents

Chapter 1. Antibiotics Market: Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Drug Class
                        1.2.2. Type
                        1.2.3. Action Mechanism
                        1.2.4. Regional scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Antibiotics Market: Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Drug Class
                        2.2.2. Type
                        2.2.3. Action Mechanism
                        2.2.4. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Antibiotics Market: Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Development of advanced products
                            3.2.1.2. Increasing prevalence of infectious diseases
                            3.2.1.3. Growing collaborations for development of antibiotics
                        3.2.2. Market restraint analysis
                            3.2.2.1. High number of patent expirations
                            3.2.2.2. High R&D cost
                    3.3. Antibiotics Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. Antibiotics Market: Drug Class Estimates & Trend Analysis
                    4.1. Drug Class Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Antibiotics Market by Drug Class Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Cephalosporin
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Penicillin
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Fluoroquinolone
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Macrolides
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.5. Carbapenems
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.6. Aminoglycosides
                            4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.7. Sulfonamides
                            4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.8. 7-ACA
                            4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.9. Others
                            4.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Antibiotics Market: Type Estimates & Trend Analysis
                    5.1. Type Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Antibiotics Market by Type Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Branded Antibiotics
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. Generic Antibiotics
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Antibiotics Market: Action Mechanism Estimates & Trend Analysis
                    6.1. Action Mechanism Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. Global Antibiotics Market by Action Mechanism Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        6.4.1. Cell Wall Synthesis Inhibitors
                            6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        6.4.2. Protein Synthesis Inhibitors
                            6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.3. DNA Synthesis Inhibitors
                            6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.4. RNA Synthesis Inhibitors
                            6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.5. Mycolic Acid Inhibitors
                            6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.6. Others
                            6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Antibiotics Market: Regional Estimates & Trend Analysis
                    7.1. Regional Market Share Analysis, 2023 & 2030
                    7.2. Regional Market Dashboard
                    7.3. Global Regional Market Snapshot
                    7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    7.5. North America
                        7.5.1. U.S.
                            7.5.1.1. Key country dynamics
                            7.5.1.2. Regulatory framework/ reimbursement structure
                            7.5.1.3. Competitive scenario
                            7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.2. Canada
                            7.5.2.1. Key country dynamics
                            7.5.2.2. Regulatory framework/ reimbursement structure
                            7.5.2.3. Competitive scenario
                            7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                    7.6. Europe
                        7.6.1. UK
                            7.6.1.1. Key country dynamics
                            7.6.1.2. Regulatory framework/ reimbursement structure
                            7.6.1.3. Competitive scenario
                            7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.2. Germany
                            7.6.2.1. Key country dynamics
                            7.6.2.2. Regulatory framework/ reimbursement structure
                            7.6.2.3. Competitive scenario
                            7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.3. France
                            7.6.3.1. Key country dynamics
                            7.6.3.2. Regulatory framework/ reimbursement structure
                            7.6.3.3. Competitive scenario
                            7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.4. Italy
                            7.6.4.1. Key country dynamics
                            7.6.4.2. Regulatory framework/ reimbursement structure
                            7.6.4.3. Competitive scenario
                            7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.5. Spain
                            7.6.5.1. Key country dynamics
                            7.6.5.2. Regulatory framework/ reimbursement structure
                            7.6.5.3. Competitive scenario
                            7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.6. Norway
                            7.6.6.1. Key country dynamics
                            7.6.6.2. Regulatory framework/ reimbursement structure
                            7.6.6.3. Competitive scenario
                            7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.7. Sweden
                            7.6.7.1. Key country dynamics
                            7.6.7.2. Regulatory framework/ reimbursement structure
                            7.6.7.3. Competitive scenario
                            7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.8. Denmark
                            7.6.8.1. Key country dynamics
                            7.6.8.2. Regulatory framework/ reimbursement structure
                            7.6.8.3. Competitive scenario
                            7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    7.7. Asia Pacific
                        7.7.1. Japan
                            7.7.1.1. Key country dynamics
                            7.7.1.2. Regulatory framework/ reimbursement structure
                            7.7.1.3. Competitive scenario
                            7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.2. China
                            7.7.2.1. Key country dynamics
                            7.7.2.2. Regulatory framework/ reimbursement structure
                            7.7.2.3. Competitive scenario
                            7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.3. India
                            7.7.3.1. Key country dynamics
                            7.7.3.2. Regulatory framework/ reimbursement structure
                            7.7.3.3. Competitive scenario
                            7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.4. Australia
                            7.7.4.1. Key country dynamics
                            7.7.4.2. Regulatory framework/ reimbursement structure
                            7.7.4.3. Competitive scenario
                            7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.5. South Korea
                            7.7.5.1. Key country dynamics
                            7.7.5.2. Regulatory framework/ reimbursement structure
                            7.7.5.3. Competitive scenario
                            7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.6. Thailand
                            7.7.6.1. Key country dynamics
                            7.7.6.2. Regulatory framework/ reimbursement structure
                            7.7.6.3. Competitive scenario
                            7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    7.8. Latin America
                        7.8.1. Brazil
                            7.8.1.1. Key country dynamics
                            7.8.1.2. Regulatory framework/ reimbursement structure
                            7.8.1.3. Competitive scenario
                            7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        7.8.2. Mexico
                            7.8.2.1. Key country dynamics
                            7.8.2.2. Regulatory framework/ reimbursement structure
                            7.8.2.3. Competitive scenario
                            7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                        7.8.3. Argentina
                            7.8.3.1. Key country dynamics
                            7.8.3.2. Regulatory framework/ reimbursement structure
                            7.8.3.3. Competitive scenario
                            7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    7.9. MEA
                        7.9.1. South Africa
                            7.9.1.1. Key country dynamics
                            7.9.1.2. Regulatory framework/ reimbursement structure
                            7.9.1.3. Competitive scenario
                            7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        7.9.2. Saudi Arabia
                            7.9.2.1. Key country dynamics
                            7.9.2.2. Regulatory framework/ reimbursement structure
                            7.9.2.3. Competitive scenario
                            7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        7.9.3. UAE
                            7.9.3.1. Key country dynamics
                            7.9.3.2. Regulatory framework/ reimbursement structure
                            7.9.3.3. Competitive scenario
                            7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        7.9.4. Kuwait
                            7.9.4.1. Key country dynamics
                            7.9.4.2. Regulatory framework/ reimbursement structure
                            7.9.4.3. Competitive scenario
                            7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. List of key distributors and channel partners
                        8.3.2. Key customers
                        8.3.3. Key company market share analysis, 2023
                        8.3.4. AbbVie, Inc.
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Pfizer Inc.
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Novartis AG
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. Merck & Co., Inc.
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. Teva Pharmaceutical Industries Ltd.
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Lupin Pharmaceuticals, Inc.
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Viatris, Inc.
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives
                        8.3.11. Melinta Therapeutics LLC
                            8.3.11.1. Company overview
                            8.3.11.2. Financial performance
                            8.3.11.3. Product benchmarking
                            8.3.11.4. Strategic initiatives
                        8.3.12. Cipla, Inc.
                            8.3.12.1. Company overview
                            8.3.12.2. Financial performance
                            8.3.12.3. Product benchmarking
                            8.3.12.4. Strategic initiatives
                        8.3.13. Shionogi & Co., Ltd.
                            8.3.13.1. Company overview
                            8.3.13.2. Financial performance
                            8.3.13.3. Product benchmarking
                            8.3.13.4. Strategic initiatives
                        8.3.14. KYORIN Pharmaceutical Co., Ltd.
                            8.3.14.1. Company overview
                            8.3.14.2. Financial performance
                            8.3.14.3. Product benchmarking
                            8.3.14.4. Strategic initiatives
                        8.3.15. GSK plc
                            8.3.15.1. Company overview
                            8.3.15.2. Financial performance
                            8.3.15.3. Product benchmarking
                            8.3.15.4. Strategic initiatives
                        8.3.16. Nabriva Therapeutics PLC
                            8.3.16.1. Company overview
                            8.3.16.2. Financial performance
                            8.3.16.3. Product benchmarking
                            8.3.16.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America Antibiotics market, by region, 2018 - 2030 (USD Million)
Table 3 North America Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 4 North America Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 5 North America Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 6 U.S. Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 7 U.S. Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 9 Canada Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 10 Canada Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 12 Europe Antibiotics market, by region, 2018 - 2030 (USD Million)
Table 13 Europe Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 14 Europe Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 15 Europe Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 16 Germany Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 17 Germany Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 18 Germany Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 19 UK Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 20 UK Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 21 UK Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 22 France Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 23 France Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 24 France Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 25 Italy Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 26 Italy Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 27 Italy Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 28 Spain Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 29 Spain Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 30 Spain Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 31 Denmark Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 32 Denmark Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 33 Denmark Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 34 Sweden Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 35 Sweden Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 36 Sweden Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 37 Norway Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 38 Norway Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 39 Norway Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Antibiotics market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 44 China Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 45 China Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 46 China Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 47 Japan Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 48 Japan Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 49 Japan Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 50 India Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 51 India Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 52 India Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 53 South Korea Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 54 South Korea Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 55 South Korea Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 56 Australia Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 57 Australia Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 58 Australia Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 59 Thailand Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 60 Thailand Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 61 Thailand Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 62 Latin America Antibiotics market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 64 Latin America Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 65 Latin America Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 66 Brazil Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 67 Brazil Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 68 Brazil Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 69 Mexico Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 70 Mexico Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 71 Mexico Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 72 Argentina Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 73 Argentina Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 74 Argentina Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 75 MEA Antibiotics market, by region, 2018 - 2030 (USD Million)
Table 76 MEA Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 77 MEA Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 78 MEA Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 79 South Africa Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 80 South Africa Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 81 South Africa Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 85 UAE Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 86 UAE Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 87 UAE Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)
Table 88 Kuwait Antibiotics market, by drug class, 2018 - 2030 (USD Million)
Table 89 Kuwait Antibiotics market, by type, 2018 - 2030 (USD Million)
Table 90 Kuwait Antibiotics market, by action mechanism, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Antibiotics market: market outlook
Fig. 14 Antibiotics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Antibiotics market driver impact
Fig. 20 Antibiotics market restraint impact
Fig. 21 Antibiotics market strategic initiatives analysis
Fig. 22 Antibiotics market: Drug Class movement analysis
Fig. 23 Antibiotics market: Drug Class outlook and key takeaways
Fig. 24 Cephalosporin market estimates and forecast, 2018 - 2030
Fig. 25 Penicillin market estimates and forecast, 2018 - 2030
Fig. 26 Fluoroquinolone market estimates and forecast, 2018 - 2030
Fig. 27 Macrolides market estimates and forecast, 2018 - 2030
Fig. 28 Carbapenems market estimates and forecast, 2018 - 2030
Fig. 29 Aminoglycosides market estimates and forecast, 2018 - 2030
Fig. 30 Sulfonamides market estimates and forecast, 2018 - 2030
Fig. 31 7-ACA market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Antibiotics Market: Type movement Analysis
Fig. 34 Antibiotics market: Type outlook and key takeaways
Fig. 35 Branded Antibiotics market estimates and forecasts, 2018 - 2030
Fig. 36 Generic Antibiotics market estimates and forecasts,2018 - 2030
Fig. 37 Antibiotics market: Action Mechanism movement analysis
Fig. 38 Antibiotics market: Action Mechanism outlook and key takeaways
Fig. 39 Cell Wall Synthesis Inhibitors market estimates and forecasts, 2018 - 2030
Fig. 40 Protein Synthesis Inhibitors market estimates and forecasts,2018 - 2030
Fig. 41 DNA Synthesis Inhibitors market estimates and forecasts,2018 - 2030
Fig. 42 RNA Synthesis Inhibitors market estimates and forecasts, 2018 - 2030
Fig. 43 Mycolic Acid Inhibitors market estimates and forecasts,2018 - 2030
Fig. 44 Others market estimates and forecasts, 2018 - 2030
Fig. 45 Global Antibiotics market: Regional movement analysis
Fig. 46 Global Antibiotics market: Regional outlook and key takeaways
Fig. 47 Global Antibiotics market share and leading players
Fig. 48 North America market share and leading players
Fig. 49 Europe market share and leading players
Fig. 50 Asia Pacific market share and leading players
Fig. 51 Latin America market share and leading players
Fig. 52 Middle East & Africa market share and leading players
Fig. 53 North America: SWOT
Fig. 54 Europe SWOT
Fig. 55 Asia Pacific SWOT
Fig. 56 Latin America SWOT
Fig. 57 MEA SWOT
Fig. 58 North America, by country
Fig. 59 North America
Fig. 60 North America market estimates and forecasts, 2018 - 2030
Fig. 61 U.S.
Fig. 62 U.S. market estimates and forecasts, 2018 - 2030
Fig. 63 Canada
Fig. 64 Canada market estimates and forecasts, 2018 - 2030
Fig. 65 Europe
Fig. 66 Europe market estimates and forecasts, 2018 - 2030
Fig. 67 UK
Fig. 68 UK market estimates and forecasts, 2018 - 2030
Fig. 69 Germany
Fig. 70 Germany market estimates and forecasts, 2018 - 2030
Fig. 71 France
Fig. 72 France market estimates and forecasts, 2018 - 2030
Fig. 73 Italy
Fig. 74 Italy market estimates and forecasts, 2018 - 2030
Fig. 75 Spain
Fig. 76 Spain market estimates and forecasts, 2018 - 2030
Fig. 77 Denmark
Fig. 78 Denmark market estimates and forecasts, 2018 - 2030
Fig. 79 Sweden
Fig. 80 Sweden market estimates and forecasts, 2018 - 2030
Fig. 81 Norway
Fig. 82 Norway market estimates and forecasts, 2018 - 2030
Fig. 83 Asia Pacific
Fig. 84 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 85 China
Fig. 86 China market estimates and forecasts, 2018 - 2030
Fig. 87 Japan
Fig. 88 Japan market estimates and forecasts, 2018 - 2030
Fig. 89 India
Fig. 90 India market estimates and forecasts, 2018 - 2030
Fig. 91 Thailand
Fig. 92 Thailand market estimates and forecasts, 2018 - 2030
Fig. 93 South Korea
Fig. 94 South Korea market estimates and forecasts, 2018 - 2030
Fig. 95 Australia
Fig. 96 Australia market estimates and forecasts, 2018 - 2030
Fig. 97 Latin America
Fig. 98 Latin America market estimates and forecasts, 2018 - 2030
Fig. 99 Brazil
Fig. 100 Brazil market estimates and forecasts, 2018 - 2030
Fig. 101 Mexico
Fig. 102 Mexico market estimates and forecasts, 2018 - 2030
Fig. 103 Argentina
Fig. 104 Argentina market estimates and forecasts, 2018 - 2030
Fig. 105 Middle East and Africa
Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 107 South Africa
Fig. 108 South Africa market estimates and forecasts, 2018 - 2030
Fig. 109 Saudi Arabia
Fig. 110 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 111 UAE
Fig. 112 UAE market estimates and forecasts, 2018 - 2030
Fig. 113 Kuwait
Fig. 114 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 115 Market share of key market players- Antibiotics market

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon